Welcome to Discovery Bioanalytical Consulting
At Discovery Bioanalytical Consulting, I specialize in providing tailored bioanalytical consulting services to biotechnology and pharmaceutical companies, as well as contract research organizations (CROs). As a bioanalytical experts, I am dedicated to helping you navigate the complexities of bioanalytical methods (PK, ADA, NAb, PD), ensuring your projects are not only successful but also compliant with industry standards. Let’s embark on this journey together and unlock the potential of your innovations.
Offerings
Expert Consultation
I bring you years of experience in bioanalytical method validation and implementation, and ensure you receive tailored advice that meets your product development phase-appropriate project needs.
Regulatory Compliance
I help navigate the complex landscape of regulatory requirements, ensuring your assays comply with the latest guidelines and standards in a phase appropriate manner.
BLA Assistance- ISI and 2.7.1
With over 50 BLA, sBLA, and NDA filings, I can provide editing, review, and writing of BLA section 2.7.1 and the Integrated Summary of Immunogenicity (ISI) documents.
About Me
With over 20 years of demonstrated expertise in the Bioanalytical field, numerous technologies (LCMS, LBA/ELISA, Molecular-qPCR, ddPCR, dPCR, cell-based-NAb and IHC), leadership, strategy, cost-effectiveness, and over 15 previously approved biologics in my repertoire, I look forward to helping you bring your innovations forward from idea to approval. Let's begin moving your biologic forward together!
Frequently Asked Questions
What services does Discovery Bioanalytical Consulting offer?
I provide a range of bioanalytical consulting services tailored for biotechnology and pharmaceutical companies, as well as contract research organizations (CROs). My expertise includes method development, validation, IND and BLA submission (bioanalytical portions), and regulatory support to ensure your projects meet industry standards.
How can I get started with your consulting services?
Getting started is easy! Simply reach out to us through our contact form or give us a call. We'll schedule a consultation to discuss your specific needs and how we can assist you in achieving your goals.
What industries do you primarily work with?
I primarily work with biotechnology and pharmaceutical companies, as well as CROs. With my extensive experience in these sectors, I can provide specialized insights and solutions. I work with companies located in North America, Europe, and Asia.
What Modalities do you have experience with?
I work in a broad range of biologics. The list includes: Monoclonal Antibodies, Bispecific Antibodies, Enzymes, Antisense Oligonucleotides, Antibody-Drug Conjugates, Peptides, complex constructs, and Cell and Gene Therapy (CGT)including in vivo expressed biologics (including both LNP-mRNA and viral vectors) and CAR-T.
Molecule Proprietary Name | Molecule Generic Name | Molecule Type | Indication | Biological Target | Role |
Imfinzi | Durvalumab | mAb | Oncology | PD-L1 | Bioanalytical Lead, Submission Lead, PK, ADA, and Nab Assay Lead, Outsourcing Lead |
Enhertu | trastuzumab-deruxtecan | ADC | Oncology | HER2 | Immunogenicity Lead, Submission Team, PK (LBA), ADA, and Nab Assay Lead, Outsourcing Lead, Co-Collaboration Lead |
Imjudo | Tremelimumab | mAb | Oncology | CTLA4 | Bioanalytical Lead, Submission Lead, PK, ADA, and Nab Assay Lead, Outsourcing Lead |
Saphnelo | Anifrolumab | mAb | SLE (Lupus) | IFNar | Bioanalytical Lead, Submission Lead, PK, ADA, and Nab Assay Lead, Outsourcing Lead |
Beyfortus | Nirsevimab | mAb | Infectious Disease | RSV (F-protein) | Bioanalytical Lead, Submission Lead, PK, ADA, and Nab Assay Lead, Outsourcing Lead |
AiRuiKa | Camrelizumab | mAb | Oncology | PD-1 | ISI Preparation |
Evusheld | AZD7442 (tixagevimab and cilgavimab) | 2 mAbs | COVID-19 | COVID-19 | Immunogenicity Strategy, Outsourcing Lead, ADA and Nab Assay Lead |
Bydureon Bcise | exenatide | peptide | T2DM | GLP-1 | Bioanalytical Lead, Submission Lead, ADA Assay Lead, Outsourcing Lead |
Trulicity | dulaglutide | peptide | T2DM | GLP-1 | Key Client Contact, PK Assay Lead |
Kynamro | Mipomersen, ISIS301012 | ASO | Hyper- cholesterolemia | apoB-100 | Key Client Contact, PK Assay Lead, ADA Assay Lead |
Xigris | drotrecogin alfa | Enzyme | Sepsis | Activated Protein C | Key Client Contact, PK Assay Lead, ADA Assay Lead, Nab Assay Lead |
Mounjaro | GIP-GLP | peptide | T2DM, Obesity | GLP-1, GIP | Key Client Contact, Discovery Bioanalysis PK Assay lead |
Covishield, Vaxzevria | ChAdOx1 | vaccine | COVID-19 | COVID-19 | Preclinical Strategy, molecular lead, DART study lead |
Kisunla | donanemab | mAb | Alheimer's | Amyloid-beta | Key Client Contact, PD Assay Lead |
Cyramza | ramucirumab | mAb | Oncology | VEGFR2 | Key Client Contact, PD Assay Lead |
Let's talk!